These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 17969102)

  • 1. Deletion of the STOP gene, a microtubule stabilizing factor, leads only to discrete cerebral metabolic changes in mice.
    Hanaya R; Koning E; Ferrandon A; Schweitzer A; Andrieux A; Nehlig A
    J Neurosci Res; 2008 Mar; 86(4):813-20. PubMed ID: 17969102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoglutamatergic activity in the STOP knockout mouse: a potential model for chronic untreated schizophrenia.
    Brenner E; Sonnewald U; Schweitzer A; Andrieux A; Nehlig A
    J Neurosci Res; 2007 Nov; 85(15):3487-93. PubMed ID: 17304567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olfactory bulbectomy reduces cerebral glucose utilization: 2-[14C]deoxyglucose autoradiographic study.
    Skelin I; Sato H; Diksic M
    Brain Res Bull; 2008 Jul; 76(5):485-92. PubMed ID: 18534256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained increase of alpha7 nicotinic receptors and choline-induced improvement of learning deficit in STOP knock-out mice.
    Bouvrais-Veret C; Weiss S; Andrieux A; Schweitzer A; McIntosh JM; Job D; Giros B; Martres MP
    Neuropharmacology; 2007 Jun; 52(8):1691-700. PubMed ID: 17512560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered expression of synaptic protein mRNAs in STOP (MAP6) mutant mice.
    Eastwood SL; Lyon L; George L; Andrieux A; Job D; Harrison PJ
    J Psychopharmacol; 2007 Aug; 21(6):635-44. PubMed ID: 17050659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The deletion of STOP/MAP6 protein in mice triggers highly altered mood and impaired cognitive performances.
    Fournet V; Schweitzer A; Chevarin C; Deloulme JC; Hamon M; Giros B; Andrieux A; Martres MP
    J Neurochem; 2012 Apr; 121(1):99-114. PubMed ID: 22146001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local cerebral glucose utilization in the AS/AGU rat: a mutant with movement disorders.
    Lam AG; Campbell JM; Bennett NK; Payne AP; Davies RW; Sutcliffe RG; McCulloch J
    Eur J Neurosci; 1998 Jun; 10(6):1963-7. PubMed ID: 9753083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in local cerebral glucose utilization associated with Parkinson's syndrome induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the primate.
    Porrino LJ; Burns RS; Crane AM; Palombo E; Kopin IJ; Sokoloff L
    Life Sci; 1987 Apr; 40(17):1657-64. PubMed ID: 3494179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression pattern of STOP lacZ reporter gene in adult and developing mouse brain.
    Couégnas A; Schweitzer A; Andrieux A; Ghandour MS; Boehm N
    J Neurosci Res; 2007 May; 85(7):1515-27. PubMed ID: 17394261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The deletion of the microtubule-associated STOP protein affects the serotonergic mouse brain network.
    Fournet V; Jany M; Fabre V; Chali F; Orsal D; Schweitzer A; Andrieux A; Messanvi F; Giros B; Hamon M; Lanfumey L; Deloulme JC; Martres MP
    J Neurochem; 2010 Dec; 115(6):1579-94. PubMed ID: 20969568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific alterations in local cerebral glucose utilization following striatal lesions.
    Kelly PA; Graham DI; McCulloch J
    Brain Res; 1982 Feb; 233(1):157-72. PubMed ID: 7059797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic mapping of the effects of intravenous methamphetamine administration in freely moving rats.
    Pontieri FE; Crane AM; Seiden LS; Kleven MS; Porrino LJ
    Psychopharmacology (Berl); 1990; 102(2):175-82. PubMed ID: 1980372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of apomorphine upon local cerebral glucose utilization in conscious rats and in rats anesthetized with chloral hydrate.
    Grome JJ; McCulloch J
    J Neurochem; 1983 Feb; 40(2):569-76. PubMed ID: 6822839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced expression of STOP/MAP6 in mice leads to cognitive deficits.
    Volle J; Brocard J; Saoud M; Gory-Faure S; Brunelin J; Andrieux A; Suaud-Chagny MF
    Schizophr Bull; 2013 Sep; 39(5):969-78. PubMed ID: 23002183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The stop null mice model for schizophrenia displays [corrected] cognitive and social deficits partly alleviated by neuroleptics.
    Bégou M; Volle J; Bertrand JB; Brun P; Job D; Schweitzer A; Saoud M; D'Amato T; Andrieux A; Suaud-Chagny MF
    Neuroscience; 2008 Nov; 157(1):29-39. PubMed ID: 18804150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local cerebral glucose utilization in monkeys with hemiparkinsonism induced by intracarotid infusion of the neurotoxin MPTP.
    Palombo E; Porrino LJ; Bankiewicz KS; Crane AM; Sokoloff L; Kopin IJ
    J Neurosci; 1990 Mar; 10(3):860-9. PubMed ID: 2319306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The suppression of brain cold-stable microtubules in mice induces synaptic defects associated with neuroleptic-sensitive behavioral disorders.
    Andrieux A; Salin PA; Vernet M; Kujala P; Baratier J; Gory-Fauré S; Bosc C; Pointu H; Proietto D; Schweitzer A; Denarier E; Klumperman J; Job D
    Genes Dev; 2002 Sep; 16(18):2350-64. PubMed ID: 12231625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the GABA receptor agonist, progabide, upon local cerebral glucose utilization.
    Cudennec A; Duverger D; Lloyd KG; MacKenzie ET; McCulloch J; Motohashi N; Nishikawa T; Scatton B
    Brain Res; 1987 Oct; 423(1-2):162-72. PubMed ID: 2823984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuronal transport defects of the MAP6 KO mouse - a model of schizophrenia - and alleviation by Epothilone D treatment, as observed using MEMRI.
    Daoust A; Bohic S; Saoudi Y; Debacker C; Gory-Fauré S; Andrieux A; Barbier EL; Deloulme JC
    Neuroimage; 2014 Aug; 96():133-42. PubMed ID: 24704457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterisation of [125I]-Tyr0DTrp8-somatostatin binding in sst1- to sst4- and SRIF-gene-invalidated mouse brain.
    Videau C; Hochgeschwender U; Kreienkamp HJ; Brennan MB; Viollet C; Richter D; Epelbaum J
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Jun; 367(6):562-71. PubMed ID: 12759718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.